Clinical trial Recruiting at 1 site Interventional Ages 18 and up

A digital tool to empower adults with congenital heart disease

Official title: Improving Care for Adults With Congenital Heart Disease

Run by University of California, San Francisco · NCT06581484 · Data updated 2026-11-12

This study is testing a digital tool called 'Empower My Congenital Health' to see if it helps adults with congenital heart disease feel more confident and engaged in managing their health.

More Congenital Heart Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedSeptember 5, 2024
Main results expectedDecember 31, 2026
Study endsAugust 31, 2027
Registry record updatedJanuary 23, 2026
Trial IDNCT06581484 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have congenital heart disease and can provide informed consent.

Probably not a fit

Patients who are developmentally delayed or unable to consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a digital health intervention called 'Empower My Congenital Health' designed to enhance the engagement and self-advocacy skills of adults with congenital heart disease (CHD). The intervention includes features such as a digital medical passport, health information, community support, and reminders for specialist visits. Participants will be recruited from clinics and through various outreach methods, and their engagement will be assessed through surveys at regular intervals. The study aims to determine if this intervention improves patient confidence in navigating the healthcare system.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the ability of adults with congenital heart disease to manage their health and access necessary care.

How similar studies have gone: Other studies have shown promise in using digital interventions for patient engagement, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* have congenital heart disease
* 18 years or older
* can sign the informed consent

Exclusion Criteria:

* developmentally delayed
* unable to consent

Where it's running

  • University of California, San Francisco
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Anushree Agarwal, MBBS, MAS — University of California, San Francisco
  • Study coordinator: Anushree Agarwal, MBBS, MAS
  • Email: anu.agarwal2@ucsf.edu
  • Phone: 415-353-3817

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.